Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article

Journal of Cardiothoracic Surgery

Baheramsjah Mochtar¹  Jos Maessen¹  Patrick Weerwind¹  Coenraad Hemker²  Saartje Bloemen²  Patty Nelemans⁴  Hugo ten Cate³  Raed Al Dieri²  Yvonne Bosch¹ 

[1] Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, P. Debeyelaan 25, PO Box 5800, 6202, AZ, Maastricht, the Netherlands;Synapse BV, Maastricht University Medical Center, PO Box 616, 6200, MD, Maastricht, the Netherlands;Department of Internal Medicine, Maastricht University Medical Center, P. Debeyelaan 25, PO Box 5800, 6202, AZ, Maastricht, the Netherlands;Department of Epidemiology, Maastricht University Medical Center, PO Box 616, 6200, MD, Maastricht, the Netherlands

关键词: CPB;    CABG;    Thrombin generation;    Blood loss;    Blood (anti)coagulation;    Bleeding;   

Others  :  824464
DOI  :  10.1186/1749-8090-8-154

 received in 2012-10-04, accepted in 2013-06-06,  发布年份 2013

【 摘 要 】

Background

In this study the value of thrombin generation parameters measured by the Calibrated Automated Thrombography for prediction of blood loss after cardiac surgery with cardiopulmonary bypass was investigated.

Methods

Thirty male patients undergoing first-time coronary artery bypass grafting were enrolled. Blood samples were taken pre-bypass before heparinisation (T1) and 5 min after protamine administration (T2). Thrombin generation was measured both in platelet-rich plasma and in platelet-poor plasma. Besides thrombin generation measurements, activated clotting time, haematocrit, haemoglobin, platelet number, fibrinogen, antithrombin, D-dimers, prothrombin time and activated partial thromboplastin time were determined. Blood loss was measured and the amount of transfusion products was recorded postoperatively until 20 hours after surgery. Patients were divided into two groups based on the median volume of postoperative blood loss (group 1: patients with median blood loss <930 ml; group 2: patients with median blood loss ≥930 ml).

Results

On T1, patients of group 2 had a significantly lower endogenous thrombin potential and peak thrombin (p<0.001 and p=0.004 respectively) in platelet-rich plasma, a significantly lower endogenous thrombin potential (p=0.004) and peak thrombin (p=0.014) in platelet-poor plasma, and a lower platelet count (p=0.002). On T2 both endogenous thrombin potential and peak thrombin remain significantly lower (p=0.011 and p=0.010) in group 2, measured in platelet-rich plasma but not in platelet-poor plasma. In addition, platelet number remains lower in group 2 after protamine administration (p=0.002).

Conclusions

The key finding is that the Calibrated Automated Thrombography assay, performed preoperatively, provides information predictive for blood loss after cardiac surgery.

【 授权许可】

   
2013 Bosch et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Groenenberg I, Weerwind PW, Everts PAM, Maessen JG: Dutch perfusion incident survey. Perfusion 2010, 25:329-336.
• [2]Coakley M, Hall JE, Evans C, Duff E, Billing V, Yang L, McPherson D, Stephens E, Macartney N, Wilkes AR, Collins PW: Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. J Thromb Haemost 2011, 9:282-292.
• [3]Innerhofer P, Kienast J: Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol 2010, 24:1-14.
• [4]Luddington RJ: Thrombelastography/thromboelastometry. Clin Lab Haematol 2005, 27:81-90.
• [5]Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W: The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008, 19:212-219.
• [6]Hemker HC, Giesen P, Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, Lecompte T, Beguin S: The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002, 32:249-253.
• [7]Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC: The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002, 88:576-582.
• [8]Orbe J, Zudaire M, Serrano R, Coma-Canella I: Martinez de Sizarrondo S, Rodriguez JA, Paramo JA. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test. Thromb Haemost 2008, 99:382-387.
• [9]Hemker HC, Giesen P, Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, Lecompte T, Beguin S: Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003, 33:4-15.
• [10]Hemker HC, Beguin S: Phenotyping the clotting system. Thromb Haemost 2000, 84:747-751.
• [11]Hemker HC, Al Dieri R, Beguin S: Thrombin generation assays: accruing clinical relevance. Curr Opin Hematol 2004, 11:170-175.
• [12]Wong RK, Sleep JR, Visner AJ, Raasch DJ, Lanza LA, De Valeria PA, Torloni AS, Arabia FA: Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis. J Extra Corpor Technol 2011, 43:19-25.
• [13]Mann KG, Brummel K, Butenas S: What is all that thrombin for? J Thromb Haemost 2003, 1:1504-1514.
• [14]Heemskerk JW, Bevers EM, Lindhout T: Platelet activation and blood coagulation. Thromb Haemost 2002, 88:186-193.
• [15]Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A: Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008, 48:2152-2158.
• [16]Kumar R, Beguin S, Hemker HC: The influence of fibrinogen and fibrin on thrombin generation–evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994, 72:713-721.
• [17]Bosch YPJ, Weerwind PW, Nelemans PJ, Maessen JG, Mochtar B: An evaluation of factors affecting activated coagulation time. J Cardiothorac Vasc Anesth 2012, 26:563-568.
• [18]Conley CL, Hartmann RC, Lalley JS: The relationship of heparin activity to platelet concentration. Proc Soc Exp Biol Med 1948, 69:284-287.
• [19]Horne MK 3rd, Chao ES: Heparin binding to resting and activated platelets. Blood 1989, 74:238-243.
• [20]Lane DA, Denton J, Flynn AM, Thunberg L, Lindahl U: Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J 1984, 218:725-732.
• [21]Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W: The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002, 95:858-865.
• [22]Schols SE, Feijge MA, Lance MD, Hamulyak K, Ten Cate H, Heemskerk JW, Van Pampus EC: Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion 2008, 48:2384-2394.
• [23]Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG: Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996, 82:13-21.